Turing’s Shkreli on drug price-hike: “It gets people talking… that’s what art is”

Martin Shkreli being photographed for his role as CIO of MSMB Capital Management. (credit: Getty Images)

Regardless of the negative opinions of Martin Shkreli, no one can deny that he has sparked a much-needed discussion about drug pricing and access—and maybe that was his goal?

The founder and CEO of Turing Pharmaceuticals has been publicly lambasted for jacking up the price of a life-saving drug—often used to treat AIDS patients and babies—by more than 5,000 percent. But he says in an exclusive interview with HipHopDX that it may all be an elaborate performance:

“To me, what I’m doing right now in the media, raising prices, all this shit, believe what you want, but it’s interesting," he said. "It gets people talking. At the end of the day, that’s what art is.”

Read 4 remaining paragraphs | Comments

You may also like...